bioAffinity Technologies, Inc. (NASDAQ:BIAFW – Get Free Report)’s share price traded up 24.4% during mid-day trading on Thursday . The company traded as high as $0.75 and last traded at $0.75. 1,000 shares traded hands during mid-day trading, a decline of 79% from the average session volume of 4,789 shares. The stock had previously closed at $0.60.
bioAffinity Technologies Price Performance
The business’s 50-day simple moving average is $0.96 and its 200-day simple moving average is $0.83.
About bioAffinity Technologies
bioAffinity Technologies, Inc, a biotechnology company, engages in developing non-invasive diagnostic tests and targeted cancer therapeutics. The company offers CyPath lung, a diagnostic test, for early detection of lung cancer. It also researches targeted therapies to treat lung cancer and other diseases of the lung at the cellular level.
Further Reading
- Five stocks we like better than bioAffinity Technologies
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- The Latest 13F Filings Are In: See Where Big Money Is Flowing
- Election Stocks: How Elections Affect the Stock Market
- 3 Penny Stocks Ready to Break Out in 2025
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- FMC, Mosaic, Nutrien: Top Agricultural Stocks With Big Potential
Receive News & Ratings for bioAffinity Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for bioAffinity Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
